Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma

This study is ongoing, but not recruiting participants.

Study NCT00610857 Information provided by University of Pittsburgh

First Received: January 28, 2008 Last Updated: January 6, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2012
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)